Niramaya Med-Formulations Private Limited - Company Profile

It is a chemicals private limited company based in New Delhi, Delhi, India, established in 2005.
2005 New Delhi, Delhi, India Struck Off
Last Updated:
Access Report
About Niramaya Med-Formulations Private Limited

Niramaya Med-Formulations Private Limited, a struck off private limited company, was established on 02 August 2005 in New Delhi, Delhi, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24232DL2005PTC139233. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Mukesh Kumar Jain (Director), Krishan Kumar Goyal (Director). Its latest AGM occurred on 30 September 2011, with the balance sheet filed on 31 March 2011. It is based at U-196 Upadhaya Blockvikas Marg Shakarpur Mkt, New Delhi, Delhi, 110092.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232DL2005PTC139233

  • Registration Number

    139233

  • Incorporation Date

    02 August 2005

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 20 Year, 6 Months
  • Last Filing with ROC 31 Mar 2011
Company report

Niramaya Med-Formulations Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Niramaya Med-Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Niramaya Med-Formulations Private Limited?
Current Directors
Name Designation Appointment Date Status
Mukesh Kumar Jain Director 02 Aug 2005 Current
Krishan Kumar Goyal Director 02 Aug 2005 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Niramaya Med-Formulations.

Enhance accessibility to Niramaya Med-Formulations's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Niramaya Med-Formulations revenue growth over time
Niramaya Med-Formulations profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Niramaya Med-Formulations?

Unlock access to Niramaya Med-Formulations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Niramaya Med-Formulations?

Unlock and access historical data on people associated with Niramaya Med-Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Niramaya Med-Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Niramaya Med-Formulations's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Niramaya Med-Formulations
Recent Activity within the Organization
  • Annual General Meeting

    Niramaya Med-Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2011 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Niramaya Med-Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2011 with Roc Delhi. was documented.

  • Director Appointment

    Mukesh Kumar Jain was appointed as a Director was appointed as a Director on 02 Aug 2005 & has been associated with this company since 20 years 6 months . was recorded as a recent event.

  • Director Appointment

    Krishan Kumar Goyal was appointed as a Director was appointed as a Director on 02 Aug 2005 & has been associated with this company since 20 years 6 months . was recorded as a recent event.

  • Company Incorporation

    Niramaya Med-Formulations Private Limited was registered on 02 Aug 2005 with Roc Delhi & aged 20 years 6 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Niramaya Med-Formulations Private Limited?

The CIN of Niramaya Med-Formulations Private Limited is U24232DL2005PTC139233.

Where is Niramaya Med-Formulations Private Limited headquartered?

Niramaya Med-Formulations Private Limited is headquartered at U-196 Upadhaya Blockvikas Marg Shakarpur Mkt, New Delhi, Delhi, 110092.

When was Niramaya Med-Formulations Private Limited incorporated?

Niramaya Med-Formulations Private Limited was incorporated on 02 August 2005.

Who are the current directors of Niramaya Med-Formulations Private Limited?

The current directors of Niramaya Med-Formulations Private Limited are

What is the primary industry of Niramaya Med-Formulations Private Limited?

The primary industry of Niramaya Med-Formulations Private Limited is Chemicals.

Is Niramaya Med-Formulations Private Limited a listed company?

Niramaya Med-Formulations Private Limited is unlisted.

What is the capital structure of Niramaya Med-Formulations Private Limited?

The authorized capital of Niramaya Med-Formulations Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available